Theravance, Inc.

NASDAQ: THRX
$16.08
+$0.00 (+0.0%)
Closing price October 22, 2021
We are seeing many key movers in the BioHealth space today as drug and biotech stocks often exhibit the most volatility of any sector.  Today’s BioHealth Business Daily includes the key moves and...
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
These are some of the top pre-market analyst upgrades and positive calls from Wall Street this Thursday morning: AEterna Zentaris (AEZS) Raised to Outperform at RBC. Akamai Tech (AKAM) Raised to Buy...
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up $1.39 to $28.97,...
Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close.  But these did all touch or breach the 52-week lows.  At the end we also broke out...
(AA) Alcoa $0.81 EPS vs $0.81e; will likely have to sweeten Alcan bid before getting any approval from Alcan.(BOT) CBOT holders approve the CME merger offer.(CACS) Carrier Access lowered...